Dynavax Files Definitive Proxy Statement
| Field | Detail |
|---|---|
| Company | Dynavax Technologies Corp |
| Form Type | DEFA14A |
| Filed Date | Jun 9, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, regulatory-filing, shareholder-information
TL;DR
DYNAX filed its proxy statement, no fee needed. Standard shareholder info.
AI Summary
Dynavax Technologies Corporation filed a DEFA14A on June 9, 2025, related to its proxy statement. This filing indicates that no fee was required for this submission, and it consists of a press release distributed to stockholders. The filing is for the definitive proxy statement.
Why It Matters
This filing is a routine regulatory submission that provides shareholders with important information regarding company matters and voting procedures, ensuring transparency and compliance.
Risk Assessment
Risk Level: low — This is a standard regulatory filing (DEFA14A) for a proxy statement, which is routine for public companies and does not inherently indicate new risks.
Key Players & Entities
- DYNAVAX TECHNOLOGIES CORP (company) — Registrant
- 20250609 (date) — Filing Date
- DEFA14A (document_type) — Filing Type
FAQ
What type of filing is this DEFA14A for Dynavax Technologies Corporation?
This DEFA14A filing is for a Definitive Proxy Statement, as indicated by the checkmark next to 'Definitive Proxy Statement' and 'Definitive Additional Materials'.
When was this DEFA14A filing submitted?
The filing was submitted on June 9, 2025, as indicated by the 'FILED AS OF DATE: 20250609' and 'DATE AS OF CHANGE: 20250609'.
Was there a filing fee associated with this DEFA14A?
No, the filing indicates 'No fee required' under the 'Payment of Filing Fee' section.
What is the primary purpose of a DEFA14A filing?
A DEFA14A filing is a definitive proxy statement filed with the SEC, providing shareholders with information about matters to be voted on at a company's annual or special meeting.
What is the business address of Dynavax Technologies Corporation?
The business address for Dynavax Technologies Corporation is 2100 POWELL STREET, SUITE 720, EMERYVILLE, CA 94608.
Filing Details
This Form DEFA14A (Form DEFA14A) was filed with the SEC on June 9, 2025 regarding DYNAVAX TECHNOLOGIES CORP.